(Q28255359)

1

0 references

Judy L Cameron

2

0 references

Barry J Hoffer

3

0 references

Richard J Smeyne

Parkinsonism and Related Disorders

4

0 references

language of work or name

English

0 references

publication date

January 2012

0 references

published in

0 references

volume

18 Suppl 1

0 references

page(s)

S147-50

0 references

cites work

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Invited Article: Nervous system pathology in sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Mechanistic approaches to Parkinson's disease pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

A tale on animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Physical activity and the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Exercise protects against MPTP-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Exercise builds brain health: key roles of growth factor cascades and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2811%2970046-3

7 January 2021